Amanda Melvin, Marketing Manager for the Companion Animal Team at MSD Animal Health said: "Research has shown that up to 20% of diabetic pets die, or are euthanised, within a year of diagnosis1 so we want to do everything we can to prevent any further increases in this figure.
"Recent circumstances have put most practices under a great deal of strain and it's become clear from the increase in calls we're receiving that there is a high demand for more information and resources to support the care of diabetic pets.
"We've therefore decided that with Pet Diabetes Month in November, our best way of supporting veterinary practices is to make them aware of, and know how to access the resources we have available to help them."
The diabetes resources include veterinary nurse clinics and training, getting the most out ofVetPen, monitoring support tools and case advice.
Veterinary professionals can subscribe for access to the materials as individuals or as a practice team.
For further information, visit https://www.msd-animal-health-hub.co.uk/ahp/caninsulin/tools.
References
Megan beat more than 100 nominees to win the Land-based and Environment Learner (LBEL) prize and achieve an overall distinction in her qualification towards becoming a registered veterinary nurse.
Megan joined the referral hospital in 2021 as a patient care assistant before deciding to train as a veterinary nurse.
She now aspires to complete the International Society of Feline Medicine Diploma and to become a clinical coach and help future student vet nurses through their qualifications.
Megan said: “I felt honoured to be nominated for the award so to win and be recognised by the wider veterinary profession is amazing."
Support for those studying to get the qualification includes access to an internal mentor, regular contact with Linnaeus’s nursing central support team, a training agreement covering things like additional CPD allowances, study time and networking opportunities specific to the candidate’s specialism.
Linnaeus also runs an internal VTS networking group to support both candidates and holders.
For VTS holders, Linnaeus now offers an enriched CPD package to support their re-certification process, which takes place every five years.
This includes an enhanced CPD budget and time allowance for attendance at international specialist conferences.
Holders are also invited to interprofessional discipline-specific away days and offered membership to a specialist organisation.
Vicky Ford-Fennah, Professional Development Manager at Linnaeus and a VTS holder in anaesthesia and analgesia (pictured), said: “Achieving the VTS status requires hard work and determination.
"This new process will provide our nurses with the support to set them up for success. It also recognises the different requirements of our VTS holders to maintain their status.
“Not only do our VTS candidates and holders improve their own skills; our education and networking opportunities enable them to share knowledge and become fantastic role models to other nurses wanting to progress their careers.
Sophie McMurrough is Nurse Team Leader in internal medicine at Northwest Veterinary Specialists in Runcorn and a VTS holder in Small Animal Internal Medicine.
She said: “Becoming a VTS holder has opened so many windows of opportunity for me. I have been able to master advanced clinical skills, teach my peers and share my knowledge through writing and speaking. I would encourage anyone with a passion for a specialist area to pursue the VTS.
Alphazium TT contains alphalactalbumin and magnesium, which, according to the company, targets the three main neurological pathways involved in the regulation of mood and emotional balance.
TVM says Alphazium TT is highly palatable, so it can be administered as a treat, making the process stress free for veterinary staff, pets and pet owners.
TVM UK’s product manager Will Peel said: "Behavioural problems are becoming increasingly common in cats and dogs and are these problems are likely to get worse with pet owners going back to work as lockdown measures lift, which could cause further stress and anxiety in pets.
"Alphazium TT can help owners address these problems whilst being highly palatable – therefore also reducing the stress of tablet administration all-round."
For more information and support materials, visit: https://www.tvm-uk.com/alphaziumtt/2520/ or contact your TVM UK Territory Manager.
Jurox says the reformulation will also help reduce waste associated with unpreserved ampule formulations and will help streamline portfolios with a requirement for only one buprenorphine listing.
Dr Dan Cripwell BSc (Hons) BVSc CertAVP (EM) CertAVP PgCert (VPS) MRCVS, Advanced Veterinary Practitioner and senior veterinary technical advisor at Jurox (UK) Limited, said: “I am delighted that Jurox can provide the UK veterinary market with this evolution of our multidose buprenorphine formulation. We constantly strive to provide the veterinary profession with first class clinical and technical support and our ability to perform in-house product research and development is also a great strength; this allows us to remain agile enough to make adaptations in an area where not much has changed in the past few years.
“In this instance, we were able to examine what improvements could be made to our existing drug portfolio and respond to the profession’s feedback with the redevelopment of the commonly utilised opioid analgesic, buprenorphine. Our hope is that, as well as the recent mixing claims added to the product licence, this development will encourage the best clinical use of the drug and, in turn, improve patient experience and outcome.”
For more information, contact your local Jurox account manager, phone 0800 500 3171, visit www.jurox.com/uk or email customerservice@jurox.co.uk.
The online risk checker, which is available at www.parassess.co.uk, asks pet owners a series of questions to assess their dog's risk from fleas, ticks, lungworm roundworm and tapeworm.
The test, which has been developed with parasitologists, takes a few minutes and appears to produce sensible results (not every test produces a "Danger, high risk, emergency, get to your vet NOW" result, as you might expect if this had been entirely produced bv the marketing department).
The subsequent report can then be shared with the vet to review it and make a treatment decision.
Being online, the test can be taken on a smartphone whilst in the practice waiting room, or on tablet or computer at home.
It might be worth sharing the test with your clients by email or social media, inviting them to book an appointment if their results suggest it is necessary.
To that end, Boehringer Ingelheim has produced a range of communication materials, such as waiting room displays and digital content for web, email, SMS, and social media.
For more information, contact your local Boehringer Ingelheim territory manager or phone 01344 746957 (UK) or 01 291 3985 (Ireland).
The BVA has partnered with Closer Still Media, the impresarios behind the London Vet Show, to organise the event. They say it will cater for 1,500 veterinary professionals and provide high-value, low-cost, practical clinical and non-clinical CPD, big issue debates, and showcase key veterinary suppliers and vendors in the exhibition in a vibrant central location.
BVA President Daniella Dos Santos said: "I’m delighted to announce the launch of BVA Live. It’s an opportunity for BVA to return to hosting our own standalone conference for the first time since BVA Congress became part of the London Vet Show in 2013. The new conference will enable the veterinary community to come together, outside of London, to develop and thrive through a programme of excellent CPD, delivered by world class speakers.
"For me the most important element of BVA Live is bringing the veterinary profession together to tackle the big issues we face and providing an opportunity to engage with BVA Officers, volunteers and staff in one central venue. By hosting the conference at the NEC, Birmingham, with its excellent direct road, rail and air links it means that we can provide a greater regional offering to the veterinary profession."
It remains to be seen what impact this new conference will have on BSAVA Congress, which for many years was pretty much the only gig in town. Then, with the London Vet Show snapping at its heels, it announced it would move north from Birmingham to Manchester from 2021. Hardly will the dust have settled, than BVA and CloserStill are filling the void. At this rate, BSAVA Congress will probably have to move to the Hebrides by 2025.
It looks like there are a lot of dice being rolled here. Will more vets want to meet in Manchester than Birmingham? Will any of us be meeting in 2021 anyway, or will coronavirus continue to limit gatherings in 2021?
For more information and to register your interest in attending, visit bvalive.vetshow.com
The two-month campaign is comprised of a series of very polished videos which are now being shared on YouTube.
The videos share the experiences of a number of veterinary professionals from PSS practices who talk to the camera first as owners themselves, and then as vets.
The College says the aim is to demonstrate to the public that their animals will receive veterinary care from empathetic practice teams committed to delivering the kind of veterinary care they would want for their own animals.
Mandisa Greene, Chair of the Practice Standards Group, said: "In order for a veterinary practice to be accredited under the Practice Standards Scheme it needs to demonstrate that it is meeting a broad range of stringent standards and undergo a rigorous independent assessment every four years.
"However, we know that awareness and understanding of the Scheme amongst animal owners is relatively low, and that there is always more we can do to help change this. We have therefore developed this digital campaign to help RCVS-accredited practices explain to animal owners what RCVS-accreditation means, and why they should care about it.
"We think it’s important that RCVS-accredited practices, which go through a great deal of effort and work to achieve their accreditation, receive the recognition they deserve and we hope that they will help us to spread the word far and wide."
Ian Holloway, RCVS Director of Communications, said: “A vital ingredient of this campaign will be the support and involvement of RCVS-accredited practice teams right across the country. Throughout the two-month campaign, we will be posting lots of wonderful video stories, pictures and PSS infographics across all of our social media channels, along with other fun ways to help spread the word.
"We’re posting launch packs to all accredited-practice premises this week, which include a variety of campaign posters to display in waiting rooms and details of how to download all the digital resources from our campaign website for use in practice and online.
"We really hope that everyone associated with an RCVS-accredited practice, including their clients, will be able to share this campaign across their own channels as widely as possible, remembering to use the campaign hashtag #YourKindOfVets, of course!"
Anyone wanting more information about the campaign should email: yourkindofvets@rcvs.org.uk.
The company says it has made the test available in response to customer demand and growing evidence that in rare cases pets living with COVID-19-positive humans can be at risk of infection.
The test will be available to veterinary surgeons in North America this week and will roll out across most of the world in the coming weeks, via the company's worldwide network of laboratories.
Jay Mazelsky, President and Chief Executive Officer of Idexx Laboratories said: "We have continued to monitor the rapidly evolving public health crisis worldwide, paying special attention to the effects on pets.
"While there is currently no evidence that dogs or cats play a role in transmitting the disease to humans, it became clear offering the test was the right thing to do when we saw clinical evidence that pets—especially cats and ferrets—can in rare cases be at risk for infection. And, we heard from our customers around the globe that veterinarians needed a testing option."
Idexx recommends the test is used when three specific criteria are met:
Idexx says leading health authorities agree with the company that transmission of the SARS-CoV-2 virus is primarily person-to-person and advise against testing asymptomatic pets. Since mid-February, the company has tested over 5,000 specimens for the virus, from cats, dogs, and horses with respiratory symptoms in 17 countries. To date, it has found no positive results, suggesting that dogs and cats living with infected people generally remain uninfected, except in rare and isolated cases.
For information about the Idexx SARS-CoV-2 (COVID-19) RealPCR Test for pets, visit idexx.com/covid19-pet-test.
For the research, 2000 pet owners were asked whether they they had bought counterfeit pet medicines online. 31.3% said yes. They were then asked if they had reported the matter. 62.2% said they had. Finally, they were asked what the outcome of their report was. 60.9% said their purchase was confirmed as a fake, suggesting that at least one in ten pet owners - probably more - have bought fake pet medicines.
Bayer says the true number of owners affected is likely to be even higher, as a further 12% of pet owners in the survey said they believed that they may have bought fake pet medicines but had not reported it.
The research also showed that 87% of shoppers purchased pet parasite prevention products from unaccredited sites that have been known to sell counterfeit pet medicines. Indeed since April this year, the VMD has removed over 500 veterinary medicine listings from online marketplaces.
The message to clients is that chasing the lowest price for veterinary medicines can be a false economy.
Photo: Can you tell whether this product is fake or not?
The 2020 OV Conference will offer up to 25 hours of CPD with lectures, workshops and Q&A sessions from world-class speakers in streams covering small animals, farm animals and equines. There will also be exclusive offers from industry sponsors and online networking opportunities.
The OV Conference provides an opportunity for OVs to discuss current topics of interest and recent developments in their work. Themes this year will include notifiable diseases, biosecurity and disease control, and export certification.
In addition to the live lectures, delegates will be able to view recordings of all the sessions on-demand for three months following the conference. The CPD on offer counts towards OV revalidation qualifications with the event open to all vets, as well as animal health paraprofessionals, nurses and practice managers.
David Babington MRCVS, Business Development Director at Improve International, said: "Moving the OV Conference online has given us an opportunity to harness the technology we use regularly in all of our veterinary training to bring OVs an exceptional but affordable CPD experience.
"Our excellent speakers are looking forward to sharing the latest updates in all aspects of OV work with our delegates and to discussing the challenges ahead, particularly in the light of the COVID-19 pandemic and with the UK moving inexorably towards leaving the EU at the end of the year.
"We’re looking forward to meeting our delegates old and new online at the OV Conference in September.”
The full programme and tickets are now available from https://officialvet.com
The first 150 tickets will get an ‘Early Bird’ 25% discount from £160 to £120+ VAT using the code UK.OV.EARLYBIRD.
The theme for this year's event, which takes place on 7th November, is the cornea. Lectures will include 'Medical Cornea', 'Cross Linking' and 'Surgical Cornea'. There will be Q&A sessions after each one.
Amongst the speakers are Chris Dixon, CertOphthal MRCVS MRCVS from Veterinary Vision Ophthalmic referrals, Christine Heinrich, RCVS & European Specialist in Veterinary Ophthalmology from the Eye Clinic and Sara Thomasy, Professor of Comparative Ophthalmology at the University of California from UC Davis University.
As is customary, abstracts will be presented throughout the day.
Tickets are £100 +VAT, or £60+Vat for students, interns and veterinary nurses: https://www.thewebinarvet.com/pages/bravo-virtual-winter-conference-2020-tickets/
The company says the battery-operated, dual-speed clipper has been specifically designed for a close cut to improve hygiene and make treatments easier.
Hefin Rowlands from Heiniger said: “The Opal Xtend will help vets with accurate hair removal for everyday tasks such as TB testing.
"It has been developed to be quieter, which will reduce stress, and has an interchangeable battery system to enable uninterrupted operation during periods of extensive use.
“An LED battery indicator provides forewarning to operators and additional batteries can be swapped out quickly and easily.
"Each battery will last up to 4 hours and the second battery only takes just over an hour to recharge.”
Heiniger claims that at 415 grams, the clipper is one of the lightest cordless models available.
Hefin added: “It is particularly well suited to preparing animals for skin testing, wound treatments and scans including ultrasounds.”
Heiniger says the clipper is also a good fit for agricultural and equine users looking for a reliable and dependable machine that can stand up to demanding use.
https://www.heiniger.co.uk/product/opal-xtend/
Probably the two most popular social media platforms for veterinary nurses in the UK are Facebook (and its various veterinary groups) and VetNurse.co.uk.
Facebook has the advantage that so many people use it to share photographs with family and friends, so they are already on the site and it is only a very short hop over to participate in a veterinary discussion group. That makes it an excellent way to get a broad opinion on almost any subject.
But, and it is a very big 'but', Facebook was never designed to be a platform for sharing clinical information or discussing cases. So, for example, you cannot see the professional qualifications of anyone contributing to the discussion unless they happen also to be your 'friend', so it can be hard to tell whether they have any idea what they're talking about, or are, in fact, the leading light.
There are various other aspects of Facebook that are problematic when it comes to clinical discussions, including the difficulty in referring back to useful information shared and the way in which 'me too' replies can drown out good quality information.
The survey aims to find out how much of a problem vet nurses think these things are, whether certain groups within the profession could be better served by social media - for example those that may find it daunting asking for help in an online group, and what features nurses would like VetNurse.co.uk to invest in.
The survey can be completed anonymously, but if you give your name at the end, you'll be entered into a draw for a case of champagne (or equivalent).
Take part here: https://www.surveygizmo.com/s3/5196601/Veterinary-Nurses-And-Social-Media-Survey
Please share this story amongst your colleagues!
The 'Lifelong Ear Partnership' resources, which were developed in conjunction with a panel of vets, are designed to help practice teams improve their owner communication and achieve owner buy-in about otitis.
To that end, Dechra has developed various owner communication tools for use in practice or to refer owners to after the consultation.
They include an owner website: www.ear-inflammation.co.uk and a postcard with QR code links to educational videos which cover clinical recommendations, treatment options and the importance of revisits.
There is also a brochure for owners and an online 4D ear model: www.4d-earmodel.com, which demonstrates a healthy ear and an ear with mild, moderate or severe otitis.
Finally, Dechra has also launched an ear cytology webinar series on Dechra Academy: www.dechra.co.uk/academy.
The course consists of tips for everything from greeting the patient to performing and interpreting cytology slides.
www.dechra.co.uk/otitis-externa.
Designed to help veterinary teams make clearer, more confident clinical decisions, the flowchart provides a step-by-step approach to diagnosing and managing ear disease in dogs and cats.
Renzo Di Florio, Technical Veterinary Adviser at Krka UK, said: “It takes you through each step, from diagnosis to treatment and long-term management, including identifying cases that might benefit from referral.
"It can also help practices to develop an otitis externa management plan protocol that’s useful for the whole team, and that’s practical and easy to integrate into existing workflows.”
One of the main messages in the flowchart is the central role of cytology in otitis management.
Tim said: “Cytology is essential to assess the level of inflammation and detect the presence of bacteria or Malassezia.
"This helps clinicians make informed decisions about whether antibiotics are truly needed.
"In contrast, culture and sensitivity testing can be misleading when used to guide topical therapy.”
https://www.krka.co.uk/veterinary-knowledge-hub
'Otitis Externa: Understanding Ear Disease’ will be presented by RCVS Recognised Specialist in Veterinary Dermatology, Former Member BVetMed CertSAD DVD PhD PgCAP FHEA MRCVS (pictured).
Virbac says the webinar will explain how Cortotic can help practices reduce antimicrobial use when treating otitis externa in dogs, whilst offering the same efficacy as a fixed-combination product.
https://bit.ly/CortoticWebinar
The two sets of guidance cover:
RCVS President Dr Mandisa Green said: “I would like to reassure my colleagues once again that we understand the extreme challenges and difficult decisions they are facing.
"The College has no interest in taking anyone to task for considered professional judgement, providing they act reasonably in the circumstances, can justify their actions and take reasonable notes.
"Sadly, we’re seeing the pandemic situation deteriorating again in the UK, but to varying degrees across the country. This presents a significant challenge in ensuring our guidance is clear and straightforward, while remaining relevant to as many people as possible.
For more information, visit: https://www.rcvs.org.uk/setting-standards/advice-and-guidance/coronavirus-covid-19/
The survey, which received 2445 responses from BVA members, found that 16% of vets and vet students have personally experienced discrimination within a veterinary workplace or learning environment in the past twelve months, while 20% had witnessed discrimination.
Senior colleagues were most commonly responsible for the discrimination (47% of incidents), with discrimination from clients accounting for 35% of incidents.
Sex discrimination was the most common type reported (44% of incidents) and was particularly prevalent in academic settings and in production animal, equine, and mixed practices.
Race discrimination was the next most commonly reported (27% of incidents).
Respondents also gave details of discrimination in relation to other protected characteristics, including age, sexuality, disability and gender reassignment.
Younger vets were more likely than older vets to have personally experienced discrimination in the past year (27% of those under 35 had experienced discrimination).
Female vets were more than twice as likely to have experienced discrimination than their male colleagues (19% and 8% respectively).
The incidence of discrimination was higher amongst vets from a range of minority ethnic backgrounds. Those who described their sexual orientation as bi, gay or lesbian were twice as likely to have personally experienced discrimination in the past year.
Despite the high incidence of discrimination reported, responses to the same survey showed that only 56% of the profession feel concerned about discrimination.
British Veterinary Association Junior Vice President Daniella Dos Santos (pictured right) said: "This is the first time anyone has collected such a significant body of evidence on this issue and the results are truly shocking. It is completely unacceptable that so many members of the veterinary team are subject to discrimination not just from clients but from members of our own profession.
"Worryingly, it seems that the scale of the issue will come as a surprise to many members of our profession and so it is vital that we all join the conversation and reflect on what role we can play to improve equality and inclusion. The veterinary team must become a safe and supportive environment for everyone. We cannot accept anything less for ourselves, for our colleagues and for our profession."
Only 12% of respondents were satisfied with how their incident had been dealt, rising to 23% among those who felt able to report. Daniella said: "Many of the experiences documented in our report are shocking and distressing and this distress is often compounded by what comes next. It was very saddening to hear that so many people have felt unable to report their experiences or that their reports were handled badly by those who received them.
"Experiencing discrimination can be very traumatic, without the ‘double-whammy’ of having your complaint dismissed or mishandled by managers or senior staff. We need to make sure everyone who experiences discrimination is able to get the outcome they deserve.
"Through the discrimination questionnaire we heard many distressing stories from vets, students, vet nurses and other colleagues. We are incredibly grateful to them for sharing these with us so that we can raise awareness of what’s happening in our veterinary workplaces."
To raise awareness of the scale of the issue, the BVA is inviting all members of the veterinary team to join a "Big Conversation on equality and inclusion in the veterinary professions", starting with the release of its report on the current situation on discrimination, which can be downloaded here, then inviting everyone to join online engagement sessions through social media and BVA members to feed in views via their regional representatives ahead of Council on 24 July.
The company points to research which showed that 42% of cats and 28% of dogs have lesions which are only detectable on x-ray1.
Failing to identify teeth with root lesions can have a significant impact on patient welfare, causing ongoing pain and eventual tooth loss.
The first priority for the CVS clinical improvement project was to review how effective its first opinion small animal practices were at using radiography in dental examinations.
In July 2021, only 16.2% of dental cases had radiography performed and clinicians were mostly using visual examination to guide decision making.
The project then identified the barriers to using dental radiography as: a lack of dental radiography equipment in a practice, a lack of clinician confidence in taking and interpreting the radiographs and a belief that pet owners would not want to pay for it.
To address the first issue, CVS installed new dental radiography machines at over 104 sites, at a cost of £615,000 over the course of the year.
The company then upskilled its vets and nurses in dental radiography - looking specifically at getting good quality radiographs and interpretation.
Finally, the company conducted an audit of each participating practice’s dental radiology data, updating it each month and sharing the results with the practices..
One year on, CVS says the data shows that 43% of dental cases in project practices are now using dental radiography as part of their consultation.
In the best cases, some practices have been using radiography in 100% of cases.
Hub Clinical Lead Deborah Komianos said: “When you open a patient’s mouth and look inside, seemingly normal teeth are oftentimes not normal.
"So vets and nurses can risk missing periodontal disease.
“Dental radiology has historically been underutilised but we believe it adds valuable information to dental consultations and is an important decision-making tool.
“We’re thrilled with the early results in our practices.
"It shows there’s been a real change of mind-set and behaviour towards using X-rays in dentistry – as well as increased confidence in execution."
Reference
The company introduced a new primary care nursing anaesthesia course in January 2021, which 360 RVNs took part in part last year.
A further 107 RVNs joined the Referral Nurse Professional Development Programme (RNPD) in Anaesthesia and Analgesia which was launched in 2020.
The three-month primary care anaesthesia course comprises nine modules, covering 25 hours of CPD, whilst the RNPD in Anaesthesia and Analgesia is a four-month course, equating to 40 hours of CPD.
Both courses cover areas such as auditing, patient care, anaesthetic monitoring and analgesia, and are accredited by the Association of Veterinary Anaesthetists (AVA).
The training was developed after Linnaeus surveyed its nurses about their ambitions for progression and anaesthesia was identified as an area for development.
Dr Andrea Jeffery, Chief Nursing Officer at Linnaeus, said: “Having spoken to our RVNs, the feedback was clear – they wanted to learn more about anaesthesia. Because we have a team dedicated to professional development for nurses, with the support of our clinical teams we could develop and deliver training on the topic, supporting more than 450 colleagues last year alone."
The company says it will now be taking on a new cohort for the primary care course every month this year, with the aim being to train smaller groups of RVNs more often.
It also plans to run the RNPD programme twice this year, because of its popularity, dates to be confirmed.
For further information visit https://www.linnaeusgroup.co.uk/medical-and-nursing/veterinary-nursing-support-team.
While nearly 50% of all Vetpol SQPs exceeded their CPD targets last year, none did so by as large a margin as Stacey, who did over 40 hours: more than 13 times her target.
Caroline Johnson, Director at Vetpol, said: “Her commitment to learning and CPD is truly inspiring.
"To have exceeded her quota by such a fantastic margin is something to be truly proud of, and perfectly exemplifies the high standards that we strive for within the SQP community and it is great to see Stacey clearly enjoying what she is learning.
"Having the opportunity to share this achievement with delegates at our recent Congress and see all of the hard work celebrated was a fantastic experience for myself and the rest of the Vetpol team.”
Vetpol also awarded three ‘SQP Ambassador’ awards to Jason Chadwick, Jordan Perkins and Paul Cartledge to appreciate their outstanding efforts to continued SQP excellence.
https://vetpol.uk
The petition follows the news that IVC is to launch its own telemedicine service, joining three others already in the game, at least one of which is pushing for a relaxation of the rules surrounding the prescription of POM-V medicines.
For clarity, veterinary surgeons are currently allowed to remote prescribe medicines for animals that meet the definition of 'under his care' (i.e. seen immediately before, or "recently enough or often enough for the veterinary surgeon to have personal knowledge of the condition of the animal or current health status of the herd or flock to make a diagnosis and prescribe").
In other words, there is nothing to stop bricks and mortar practices offering video consultations and prescribing medicines to those of their existing clients that they have seen recently enough.
What Shams and the BVU are petitioning against is the idea of allowing companies staffed by veterinary surgeons to prescribe veterinary medicines for animals that they have never seen in the flesh.
They argue that remote prescribing will:
First and foremost risk animal patient welfare and herd health
Create a two-tier system of care within the profession
Break down the practice-based vet-client relationship
Disrupt veterinary services due to complications related to out-of-hours emergency cover, transfer of patient and patient histories etc. of remotely treated patients
Cause clients to face increased costs by paying for telemedicine consultations and then requiring examination and treatment in practice
Negatively impact the financial condition of veterinary practices and professionals.
These all seem very possible consequences of allowing remote prescribing, indeed some have already come to pass in the world of human medicine following the launch of Babylon.
The counter argument is that remote prescription will improve access to veterinary care as people don’t have to flog down to the practice for a flea treatment and the cost of a consultation is reduced. There is surely truth in that.
The other point that is fundamental to this debate is the type of drug being prescribed remotely. With so many small animal parasiticides having already gone OTC, is it really necessary to talk to a veterinary surgeon before buying a POM-V flea treatment? Perhaps not.
However, that doesn’t necessarily present a case for remote prescribing such drugs; if they don’t need veterinary input, then you could equally argue they just need reclassifying.
So, should you sign this petition? Well, I think so, yes. Remote prescribing will come. It’s inevitable. But given the risks, surely the pragmatic starting point is to trial remote prescribing amongst existing clients of bricks and mortar practices, and only if that is successful to broaden it to non-clients of bricks and mortar practices.
If both those proved successful, and with technology advancing in the background, it might then be sensible to look at whether non bricks and mortar practices could remote prescribe. But that’s quite a big ‘might’.
Meantime, you can sign the petition here: https://www.change.org/p/royal-college-of-veterinary-surgeons-stop-authorising-prescription-of-pom-v-without-physical-examination-of-the-patient
You can discuss the petition with Shams here: https://www.vetnurse.co.uk/nonclinical/f/5/t/31671.aspx
The content covers the main points in the WSAVA’s report and offers up-to-date information and advice.
For example, Virbac highlights how the report raises concerns about increasing moves to early neutering, or for neutering to be used as a method of behavioural control, as not all aggressive behaviours are testosterone related.
For that reason, a “castration trial’ with long-acting GnRH agonist is recommended by the report before irreversible orchiectomy is performed.
In addition, there is also evidence that gonadectomy may contribute to the development of some tumours, which is currently under intense investigation, as is the effect of age at castration
Dr Neil Mottram, Technical Manager at Virbac, said: "There is so much new information to assimilate.
"So the educational reproductive resource is designed to make that journey easier to navigate and provide vets with easy access to up to the minute information on key issues in the report’.
To access the materials visit: https://vet-uk.virbac.com/home/resource-library.html, or contact your territory manager.
Samantha, who was a recipient of the Malaysian Prime Minister’s Scholarship, has a degree in genetics, molecular biology and microbiology, and a PhD in cancer research from University College London.
She was diagnosed with ADHD at the age of 40, which led her to set up ADHD Girls, an organisation that helps people with ADHD access employment and works with businesses to help them understand ADHD.
Samantha's talk is part of a module on neurodiversity, which will open with an exploration of neurodiversity and the challenges of diagnosis, before looking at how you can better support those in practice teams, as well as neurodivergent clients and students.
The session will wrap up with a discussion about how to cultivate greater inclusivity and understanding around those who are neurodivergent within the veterinary professions.
Being neurodivergent means that your brain works differently from the average person, meaning there may be differences in social preference, ways of communicating, ways of learning and ways of perceiving the environment.
Samantha said: “No two brains are the same. But what if you were born with a brain that constantly makes you feel like everything you do differentiates you from everyone else?”
“My talk introduces neurodiversity in the context of society, casting light on ADHD and autism, and how this impacts the workplace and one’s quality of life, and what we can do to build a compassionate culture, starting with the conversations we have at work.
"I’m really excited to talk at the BSAVA Congress and meet other professionals in the veterinary field.”
After her lecture, she will be partaking in a panel discussion around the challenges of diagnosis of neurodivergence alongside Laura Playforth, a vet who has been diagnosed with both bipolar and autism and is currently Group Quality Improvement Director at IVC Evidensia.
Andy Green, Vice Chair of the BSAVA Congress Programme Committee chair said: “We are delighted to have Samantha delivering our keynote this year on such an important topic.
"Neurodiversity is becoming an increasingly important area of focus and understanding across society and we have a significant population of neurodivergent people working as vets, nurses and in other roles, many of whom may not as yet have a diagnosis.”
“We also need to recognise that many pet owners and clients are neurodivergent.
"Samantha is ideally placed to shine a spotlight on this subject, using her own story and life experience to deliver a greater understanding of what it actually means to be neurodivergent and how businesses/practices can understand, embrace and support neurodivergent members of the work force and community.”
Early bird tickets for BSAVA Congress 2023 are currently on sale with 3-day and 1-day tickets available to purchase. Get your ticket now: https://www.bsavaevents.com/bsavacongress2023/en/page/home.